ON-TRK

PrOspective Non-interventional study in patients with locally advanced or metastatic TRK fusion cancer treated with larotrectinib
Contact phone
Clinical Trial Office – 517-364-9400
Trial Category
Cancer
Trial SubCategory
Genomic